Results 81 to 90 of about 9,717 (178)

Complement Hyperactivation Is Mediated by Alternative and Lectin Pathways During Early Phase of Severe Vaccination‐Omicron BA.5 Infection

Journal of Medical Virology, Volume 98, Issue 3, March 2026.
ABSTRACT Complement temporal activation kinetics, activation pathways, and their relationship with thromboinflammation and antibody responses in severe vaccination‐COVID‐19 remains unclear. Based on a vaccinated‐infected cohort, we analyzed complement immune responses across mild to critical COVID‐19 cases by a dynamic model.
Jinpeng Cao, Gang Yang, Tingting Cui, Jian Qin, Deyi Huang, Shiqin Jin, Xiaoyun Yang, Mingzhu Huang, Xiaoling Su, Siyi Liu, Yingjiao Xia, Shidong Deng, Chengna Luo, Zhuxiang Zhao, Yunhui Zhang, Nanshan Zhong, Zhongfang Wang   +16 more
wiley   +1 more source

Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats

Human Vaccines & Immunotherapeutics, 2018
Vaccination is the most effective method of preventing the spread of the influenza virus. However, the traditional intramuscular (IM) immunization causes fear, pain, and cross infection.
Shanshan Zhou, Tianyu Ren, Hongjing Gu, Cheng Wang, Min Li, Zhongpeng Zhao, Li Xing, Liangyan Zhang, Yi Sun, Penghui Yang, Xiliang Wang   +10 more
doaj   +1 more source

Emerging zoonosis of a novel avian influenza A (H7N9) Virus. Are we prepared in the neotropics?

Revista Mvz Cordoba, 2013
Zoonotic diseases represents a 78% of emerging and reemerging diseases, virus has an important proportion in zoonosis. We are not amazing anymore, we frequently see new virus that suddenly appears producing high morbidity and mortality, and all of them ...
Salim Mattar V, Marco González T
doaj   +1 more source

Sex Differences in Lung Immunity

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Biological sex has a significant impact on how the immune system develops and responds to foreign and self‐antigens. Sex differences exist in innate and adaptive immune cells, both at homeostasis and in the context of infection and inflammatory diseases such as asthma, cancer, and autoimmune disorders.
Franz Puttur, Clare M. Lloyd
wiley   +1 more source

Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design

Frontiers in Microbiology, 2017
Severe H7N9 avian influenza virus (AIV) infections in humans have public health authorities around the world on high alert for the potential development of a human influenza pandemic. Currently, the newly-emerged highly pathogenic avian influenza A (H7N9)
Zenglei Hu, Zenglei Hu, Xinan Jiao, Xinan Jiao, Xinan Jiao, Xinan Jiao, Xiufan Liu, Xiufan Liu, Xiufan Liu, Xiufan Liu   +9 more
doaj   +1 more source

Emergence of a new strain of the avian influenza A (H7N9) virus

Respiratory Investigation, 2013
The first 3 cases of infection with a novel avian-origin reassortant influenza A (H7N9) virus were identified in China between February and March 2013. The cases were characterized by rapidly progressive pneumonia, respiratory failure, and acute respiratory distress syndrome leading to fatal outcome. Up till April 30, 2013, a total of 128 cases of H7N9
openaire   +2 more sources

Diversity of the RNA Polymerase in the H7N9 Influenza A Virus

Advances in Microbiology, 2015
A novel influenza virus of the H7N9 subtype has infected more than 350 people in China since 19 February 2013. Evolutionary analysis indicates that the virus is a reassortant originated from H7, N9 and H9N2 avian influenza viruses, and bears some amino acids associated with mammalian receptor binding, raising concern over the possibility of a new ...
Jing Li, Wenjun Liu
openaire   +2 more sources

Treatment of Highly Pathogenic H7N9 Virus-Infected Mice with Baloxavir Marboxil

Viruses, 2019
Viral neuraminidase inhibitors show limited efficacy in mice infected with H7N9 influenza A viruses isolated from humans. Although baloxavir marboxil protected mice from lethal challenge infection with a low pathogenic avian influenza H7N9 virus isolated
Maki Kiso, Seiya Yamayoshi, Yuri Furusawa, Masaki Imai, Yoshihiro Kawaoka   +4 more
doaj   +1 more source

Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus

Emerging Infectious Diseases, 2018
The recent emergence of highly pathogenic influenza A(H7N9) variants poses a great risk to humans. We show that ferrets vaccinated with low pathogenicity H7N9 virus vaccine do not develop severe symptoms after infection with an antigenically distinct ...
Masato Hatta, Gongxun Zhong, Shiho Chiba, Tiago J.S. Lopes, Gabriele Neumann, Yoshihiro Kawaoka   +5 more
doaj   +1 more source

The Character of Influenza Virus the H7 Subtype and Alert to Novel Influenza Virus H7N9 Subtype Virus

Indonesian Bulletin of Animal and Veterinary Sciences, 2014
Influenza virus subtype H7 influenza viruses as well as other influenza virus geographically divided into two distinct genetic lineages, North American (H7N2, H7N3) or Eurasian (H7N7 and H7N3). Unlike the AI virus subtypes H5, since 1997 until now, all the infections caused by the H5 virus has Neuraminidase subtype 1 but H7 subtype of AI virus that ...
NLP Indi Dharmayanti, Bahri S
openaire   +1 more source